Valid for Submission
Z12.79 is a billable diagnosis code used to specify a medical diagnosis of encounter for screening for malignant neoplasm of other genitourinary organs. The code Z12.79 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.
The code Z12.79 describes a circumstance which influences the patient's health status but not a current illness or injury. The code is unacceptable as a principal diagnosis.
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code Z12.79 are found in the index:
The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:
Present on Admission (POA)
Convert Z12.79 to ICD-9 Code
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code Z12.79 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
Information for Patients
Also called: Carcinoma, Malignancy, Neoplasms, Tumor
Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for where they start. For example, lung cancer starts in the lung, and breast cancer starts in the breast. The spread of cancer from one part of the body to another is called metastasis. Symptoms and treatment depend on the cancer type and how advanced it is. Most treatment plans may include surgery, radiation and/or chemotherapy. Some may involve hormone therapy, immunotherapy or other types of biologic therapy, or stem cell transplantation.
NIH: National Cancer Institute
- Cancer (Medical Encyclopedia)
- Cancer and lymph nodes (Medical Encyclopedia)
- Cancer treatment -- early menopause (Medical Encyclopedia)
- Cancer treatment: preventing infection (Medical Encyclopedia)
- Cancer treatments (Medical Encyclopedia)
- How to research cancer (Medical Encyclopedia)
- How to tell your child that you have cancer (Medical Encyclopedia)
- Hyperthermia for treating cancer (Medical Encyclopedia)
- Laser therapy for cancer (Medical Encyclopedia)
- Photodynamic therapy for cancer (Medical Encyclopedia)
- Targeted therapies for cancer (Medical Encyclopedia)
- Understanding your cancer prognosis (Medical Encyclopedia)
- Your cancer care team (Medical Encyclopedia)
- Your cancer diagnosis: Do you need a second opinion? (Medical Encyclopedia)
[Learn More in MedlinePlus]
Also called: Screening tests
Screenings are tests that look for diseases before you have symptoms. Screening tests can find diseases early, when they're easier to treat. You can get some screenings in your doctor's office. Others need special equipment, so you may need to go to a different office or clinic.
Some conditions that doctors commonly screen for include
- Breast cancer and cervical cancer in women
- Colorectal cancer
- High blood pressure
- High cholesterol
- Overweight and obesity
- Prostate cancer in men
Which tests you need depends on your age, your sex, your family history, and whether you have risk factors for certain diseases. After a screening test, ask when you will get the results and whom to talk to about them.
Agency for Healthcare Research and Quality
[Learn More in MedlinePlus]